NAD+ is the odd one out in a research-peptide catalogue, and that is the first thing worth saying plainly: it is not a peptide. It contains no amino acids and no peptide bonds. It is a dinucleotide — two nucleotides joined by a pyrophosphate bridge — and it behaves like one. Nearly everything researchers know about handling peptides transfers badly to it. This guide covers what the molecule actually is, the two distinct jobs it does in a cell, and the handling differences that matter.
SOMA Research supplies NAD+ for laboratory research use only. It is not a drug, supplement, food or cosmetic, is not approved by the FDA for any use, and is not intended for human or veterinary consumption.
What NAD+ is
- Full name: β-Nicotinamide adenine dinucleotide
- CAS number: 53-84-9 (free acid)
- Molecular formula: C21H27N7O14P2
- Molecular weight: approximately 663.4 g/mol (free acid)
- Structure: nicotinamide mononucleotide joined to adenosine monophosphate through a pyrophosphate linkage
- Appearance: white to off-white powder
Two halves, each a nucleotide. The adenine half is structural and provides the recognition surface enzymes bind. The nicotinamide half is where the chemistry happens.
The two jobs, and why the distinction matters
NAD+ does two mechanistically unrelated things, and conflating them is the most common error in secondary writing about it.
1. As a redox coenzyme, it is recycled. The nicotinamide ring accepts a hydride ion to become NADH, then gives it up again to return to NAD+. Nothing is consumed; the molecule cycles. This is the role in central metabolism, and the pool turns over without being depleted.
2. As a substrate, it is consumed. A separate set of enzymes — sirtuins, PARPs, CD38 and related NAD+-consuming enzymes — cleave the molecule, using the ADP-ribose portion and releasing nicotinamide. This is destructive. The molecule does not come back.
Only the second role depletes the pool, and it is the one most of the current research interest attaches to. An experiment measuring “NAD+ levels” is measuring the balance between consumption by that second set of enzymes and resynthesis through the salvage pathway — not anything about the redox cycle.
A measurement the redox pair gives you for free
NAD+ and NADH differ optically. Both absorb at 260 nm through the adenine ring, but only the reduced form, NADH, absorbs at 340 nm. The oxidised form does not.
That single fact underpins a very large fraction of classical enzymology: any reaction that interconverts the two can be followed in real time on a spectrophotometer at 340 nm, with no label and no stopping the reaction. It is also a practical purity check — appreciable 340 nm absorbance in a solution that should be pure NAD+ means reduced material is present.
Why the handling rules differ from a peptide
This is the part that catches people. NAD+ fails in ways peptides do not.
- It is unstable in alkaline solution. NAD+ degrades at elevated pH. Peptide workflows often default to mildly basic buffers; that is actively harmful here. Slightly acidic to neutral conditions are preferred, and stock solutions should not be left sitting in a basic buffer.
- NADH has the opposite preference. The reduced form is unstable under acidic conditions. The two halves of the redox pair are destabilised by opposite ends of the pH scale, which means there is no single buffer that preserves both — a point that matters when preparing standards for an assay that measures both.
- It is strongly hygroscopic. More so than a typical lyophilised peptide. Bring vials fully to room temperature before opening, and weigh quickly; absorbed water skews a gravimetric measurement directly.
- No oxidation-of-residues failure mode. There is no methionine, cysteine or tryptophan to oxidise, so the degradation signatures familiar from peptides (+16 Da and so on) do not apply. Hydrolysis of the pyrophosphate bridge and pH-driven decomposition are the routes that matter instead.
- Freeze-thaw cycling should still be avoided, as with any stock solution.
Analytical characterisation
The methods carry over; the expectations do not.
- HPLC purity. Reversed-phase works, but NAD+ is highly polar and charged, so retention on a standard C18 gradient is short and ion-pairing or a polar-retentive column is often used instead. As with any very polar analyte, a main peak eluting near the void deserves scrutiny of the method, not just the percentage.
- Mass spectrometry. Identity against approximately 663.4 g/mol. The molecule ionises well in negative mode because of the two phosphates, which is the opposite of the positive-mode convention for peptides.
- UV ratio. The 260/340 relationship described above is a direct and cheap indicator of reduced-form contamination and does not require a chromatogram.
- Purity figures are not comparable to peptide figures. NAD+ is not made by solid-phase synthesis, so there is no population of deletion sequences and the impurity profile is different in kind. Comparing an NAD+ purity percentage against a peptide’s is comparing two different measurements that happen to share a unit.
Every SOMA lot is tested by third-party laboratories, with measured figures published per lot in our CoA library. Our Certificate of Analysis guide explains how to read the fields.
Storage
- Powder: -20°C, protected from light and from moisture. Keep desiccated.
- Before opening: full equilibration to room temperature, because of the hygroscopicity.
- Solutions: prepare fresh where the experiment allows. Store at 2–8°C short term, aliquoted, and keep away from alkaline buffers.
The general reconstitution arithmetic in our reconstitution guide applies, with the pH caveats above taking precedence.
Related guides
Research use only
Research-grade NAD+ is supplied for laboratory use by qualified researchers and institutions. It is not manufactured to pharmaceutical standards, has not been approved by the FDA for any use, and must not be used in or on humans or animals. Nothing in this guide is medical advice or a representation that the compound is safe or effective for any purpose.
